Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Sep;83(1):161–167. doi: 10.1111/j.1476-5381.1984.tb10131.x

Pharmacological analysis of the responsiveness of guinea-pig lung parenchymal strip to dopamine.

J Cortijo, J Esplugues, E J Morcillo, M Perpiñá
PMCID: PMC1987174  PMID: 6487886

Abstract

Responses to dopamine were examined in the guinea-pig isolated lung parenchymal strip. Complete cumulative concentration-response curves to dopamine exhibited a biphasic pattern with a small initial contraction at concentrations below 10(-5) M followed by a dose-dependent relaxation at higher concentrations. Phentolamine (10(-5) M) completely abolished the contractile component and enhanced sensitivity and maximal relaxation to dopamine. In the presence of phentolamine, propranolol antagonized the dopamine-induced relaxation (pA2 = 8.54 +/- 0.07). In the presence of propranolol (10(-6) M), dopamine produced a dose-related contraction displaced to the right by phentolamine. Incubation with haloperidol (10(-5) M) did not modify the characteristics of the concentration-response curve to dopamine. Pretreatment with reserpine abolished the contraction to dopamine without affecting its relaxant response. Cocaine significantly increased the pD2 value of dopamine in the presence of propranolol. It is concluded that dopamine produced both relaxation of lung parenchymal strip due to direct activation of beta-adrenoceptors and contraction mediated through direct and indirect (catecholamine release) actions at alpha-adrenoceptors. There is no evidence in favour of the existence of specific dopamine-receptors in this preparation.

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aviado D. M., Sadavongvivad C. Pharmacological significance of biogenic amines in the lungs: noradrenaline and dopamine. Br J Pharmacol. 1970 Feb;38(2):374–385. doi: 10.1111/j.1476-5381.1970.tb08525.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Evans J. N., Adler K. B. The lung strip: evaluation of a method to study contractility of pulmonary parenchyma. Exp Lung Res. 1981 Aug;2(3):187–195. doi: 10.3109/01902148109052314. [DOI] [PubMed] [Google Scholar]
  4. Eyre P. Release of dopamine from bovine lung by specific antigen and by compound 48-80. Br J Pharmacol. 1971 Jul;42(3):423–427. doi: 10.1111/j.1476-5381.1971.tb07127.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FALCK B., NYSTEDT T., ROSENGREN E., STENFLO J. DOPAMINE AND MAST CELLS IN RUMINANTS. Acta Pharmacol Toxicol (Copenh) 1964;21:51–58. doi: 10.1111/j.1600-0773.1964.tb01768.x. [DOI] [PubMed] [Google Scholar]
  6. GADDUM J. H., HAMEED K. A., HATHWAY D. E., STEPHENS F. F. Quantitative studies of antagonists for 5-hydroxytryptamine. Q J Exp Physiol Cogn Med Sci. 1955 Jan;40(1):49–74. doi: 10.1113/expphysiol.1955.sp001097. [DOI] [PubMed] [Google Scholar]
  7. Goldberg L. I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972 Mar;24(1):1–29. [PubMed] [Google Scholar]
  8. Goldberg L. I., Volkman P. H., Kohli J. D. A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol. 1978;18:57–79. doi: 10.1146/annurev.pa.18.040178.000421. [DOI] [PubMed] [Google Scholar]
  9. Goldie R. G., Paterson J. W., Wale J. L. Pharmacological responses of human and porcine lung parenchyma, bronchus and pulmonary artery. Br J Pharmacol. 1982 Aug;76(4):515–521. doi: 10.1111/j.1476-5381.1982.tb09248.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Koga Y., Downes H., Taylor S. M. Direct and indirect actions of dopamine on tracheal smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 1980;315(1):15–20. doi: 10.1007/BF00504225. [DOI] [PubMed] [Google Scholar]
  11. Lulich K. M., Mitchell H. W., Sparrow M. P. The cat lung strip as an in vitro preparation of peripheral airways: a comparison of beta-adrenoceptor agonists, autacoids and anaphylactic challenge on the lung strip and trachea. Br J Pharmacol. 1976 Sep;58(1):71–79. doi: 10.1111/j.1476-5381.1976.tb07694.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McNay J. L., Goldberg L. I. Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther. 1966 Jan;151(1):23–31. [PubMed] [Google Scholar]
  13. Morcillo E., Perpiñ M., Esplugues J. Responsiveness to tyramine in isolated lung parenchymal strip of guinea-pig and rat. Eur J Pharmacol. 1984 Jan 13;97(1-2):13–19. doi: 10.1016/0014-2999(84)90507-7. [DOI] [PubMed] [Google Scholar]
  14. Siegl P. K., Orzechowski R. F. Alpha- and beta-adrenergically mediated responses in isolated lung strips of guinea pigs. Res Commun Chem Pathol Pharmacol. 1981 Jun;32(3):459–472. [PubMed] [Google Scholar]
  15. Siegl P. K., Rossi G. V., Orzechowski R. F. Isolated lung strips of guinea pigs: responses to beta-adrenergic agonists and antagonists. Eur J Pharmacol. 1979 Feb 15;54(1-2):1–7. doi: 10.1016/0014-2999(79)90400-x. [DOI] [PubMed] [Google Scholar]
  16. Takenaka F., Morishita H. Possible mechanisms involved in the coronary vasodilatory response to dopamine. Arch Int Pharmacodyn Ther. 1976 Jul;222(1):81–93. [PubMed] [Google Scholar]
  17. Thomson N. C., Patel K. R. Effect of dopamine on airways conductance in normals and extrinsic asthmatics. Br J Clin Pharmacol. 1978 May;5(5):421–424. doi: 10.1111/j.1365-2125.1978.tb01648.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES